CIK: 1296543 - Address: 3333 Lee Parkway Suite 600, Dallas, TX 75219
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret212-3-18-18423410624
P%wins500050505033

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/3/15 14:33
7/31/15
ABEOAbeona Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsAhn Mark JTXDP1005.502186343D-68-50105128-2-3982-14-28-38-61-56
1/26/15 16:25
1/26/15
PTBIPlasmatech Biopharmaceuticals IncDEHealthDrugPharmaceutical PreparationsAhn Mark JORDP.d1004.00025New25D
12/7/11 16:16
12/7/11
GALEGalena Biopharma, Inc.HealthDrugPharmaceutical PreparationsAhn Mark JORDOP,CEOP70.659001010020D-79-86-54-46-33-236-21-8-21-8122129268
4/20/11 11:09
4/20/11
RXIIRxi Pharmaceuticals CorpHealthDrugPharmaceutical PreparationsAhn Mark JMADOP,CEOP100.9500010New10D
5/18/06 15:09
5/17/06
HNABHana Biosciences IncDEHealthDrugPharmaceutical PreparationsAhn Mark JCADOP,CEOP.d509.07062238B
3/27/06 09:11
3/24/06
HNABHana Biosciences IncDEHealthDrugPharmaceutical PreparationsAhn Mark JCADOP,CEOP.d1110.6301261B
10/21/05 13:48
10/19/05
HNABHana Biosciences IncDEHealthDrugPharmaceutical PreparationsAhn Mark JCADOP,CEOP.d504.590112260M
7/18/05 15:59
7/15/05
HNABHana Biosciences IncDEHealthDrugPharmaceutical PreparationsAhn Mark JCADOP,CEOP.d31.6302450D
4/29/05 15:44
4/22/05
HNABHana Biosciences IncDEHealthDrugPharmaceutical PreparationsAhn Mark JCADOP,CEOP.d501.2803943448M
1/21/05 16:22
1/19/05
HNABHana Biosciences IncDEHealthDrugPharmaceutical PreparationsAhn Mark JCADOP,CEOP.d102.4804New4M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact